Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Source: SeekingAlpha
2026-03-06 08:28:08 ET
More on Thermo Fisher Scientific, Arcutis Biotherapeutics, etc.
- Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
- Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Thermo Fisher Scientific: Recovery In Life Sciences Solutions
- Masimo Q4 2025 Earnings Preview
- Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Read the full article on Seeking Alpha
For further details see:
Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Elanco Animal Health Incorporated
NASDAQ: ELAN
ELAN Trading
-2.07% G/L:
$23.175 Last:
1,215,946 Volume:
$23.23 Open:
ELAN Latest News
February 24, 2026 06:27:00 am
Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results
ELAN Stock Data
$12,716,326,237
491,894,838
0.21%
216
N/A
Pharmaceuticals
Healthcare
US
Indianapolis
